Clinical Trials Browser

Withdrawn × HER2-positive Breast Cancer × pertuzumab × Clear all

NCT04419181 2025-10-14

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Phase 2 Withdrawn

HER2-positive Breast Cancer